US Patent 7186797 Polypeptide conjugates with extended circulating half-lives

Patent 7186797 was granted and assigned to EPIX Pharmaceuticals, Inc. on March, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 4 Sep, 2024

"update inverses"

Golden AI

edited on 4 Sep, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12076366 Therapeutic vitamin D conjugates

Edits on 6 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 6 Sep, 2023

Edits made to:

Infobox (+4 properties)

Infobox

Patent Inventor Names

Andrew Kolodziej0

Stephane Dumas0

Theodore R. West0

Thomas J McMurry0

Edits on 1 Sep, 2023

"Add patent abstract"

Golden AI

edited on 1 Sep, 2023

Edits made to:

Article (+319 characters)

Article

Patent abstract

The present invention relates to compounds and methods for synthesizing compounds wherein the compounds exhibit extended circulating half-life in the blood. The increase in circulating half-life is achieved by conjugating polypeptides to binding groups that exhibit high affinity for human serum albumin.

Edits on 24 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 24 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=071867970

Edits on 23 May, 2023

"Remove leading 0 from patent number"

Golden AI